DaVita Enters Agreement to Expand Operations in Brazil and Colombia and Enter Chile and Ecuador

128

DaVita Inc., a leading provider of kidney care services, has announced its plans to expand its international presence with strategic acquisitions in Brazil, Colombia, Chile, and Ecuador. These acquisitions, totaling USD 300 million, involve separate transactions with Fresenius Medical Care, a prominent healthcare company. The transaction in Chile has already been completed, effective today, while those in Ecuador, Colombia, and Brazil are pending regulatory approvals, expected to be finalized throughout 2024.

Upon the completion of these acquisitions, coupled with DaVita’s existing operations in Brazil and Colombia, the company will boast a network of over 15,000 teammates delivering high-quality clinical care to more than 60,000 patients across more than 270 clinics. This expansion solidifies DaVita’s position as the largest provider of dialysis services in Latin America.

Robert Lang, President of DaVita International, expressed enthusiasm about integrating the new caregivers into DaVita’s global network. He emphasized the company’s commitment to leveraging its clinical expertise and investing in local teams to ensure the delivery of exceptional care to kidney disease patients. Lang reiterated DaVita’s dedication to maintaining the established quality of the acquired centers while enhancing their services during the transition.

DaVita’s international operations span 12 countries outside of the United States. With the completion of the announced transactions, its patient base will have grown significantly, from serving 23,000 patients in 2017 to more than 79,000 patients currently. The company remains focused on its mission of providing life-sustaining care and making a positive impact on healthcare communities worldwide.